San Francisco-based telemental health company Brightside Health secured $33 million in Series C funding from S32 and investors including Kennedy Lewis, Time BioVentures, and Anne Wojcicki. The funding brings their total raised amount to $100 million. The company provides care for anxiety, depression, and other mood disorders through a Crisis Care psychiatry platform. The funding will be used to expand into new markets and deepen their advantage in technology and AI. Brightside also announced partnerships with Medicare and Medicaid providers, allowing them to serve an additional 50 million beneficiaries across multiple states. Former Optum CEO Trip Hofer joined their board of directors.
Source link
Brightside Health secures $33 million in Series C funding
